Experience the 2025 International Symposium of Gastrointestinal Oncology (ISGIO) LIVE in Austin Tx or Streamed ONLINE ! Join leading experts for two days of case-based learning, interactive panels, and cutting-edge updates in GI cancer care. (CME). 👉 FREE HCP Registration (USE

Tanios S. Bekaii-Saab, MD, (Tanios Bekaii-Saab, MD) of Mayo Clinic Comprehensive Cancer Center discusses sequencing approaches in metastatic pancreatic cancer and colorectal cancer. Read more here: hubs.li/Q03CcZ_B0

How Chemoimmunotherapy, PRRT, and First-Line Immunotherapy Are Reshaping GI Cancer Management Tanios Bekaii-Saab, MD Mayo Clinic Comprehensive Cancer Center #HCC #esophagealcancer #oncology onclive.com/view/how-chemo…

Excited to share our latest publication in @TheOncologist! 🚀 Our network meta-analysis compares multimodality treatments for resectable gastric & GEJ adenocarcinoma. Key question: What’s the optimal regimen? Spoiler: pFLOT shines! academic.oup.com/oncolo/article… . #Oncology

Experience the 2025 International Symposium of Gastrointestinal Oncology (ISGIO) LIVE in Austin Tx or Streamed ONLINE ! 👉 FREE HCP Registration (USE CODE: ONCOALERT )🚨 buff.ly/KVngjav Join leading experts for two days of case-based learning, interactive panels, and

🤠The countdown is ON—just 1 month until #ISGIO2025! Get ready to join us in Austin, TX for cutting-edge science, expert debates, and the latest breakthroughs in #GIOncology. Use code AUSTIN for 75% off HCP registration: tinyurl.com/ydm5tmvb

Great Honor hosting Tom Flaig for grand rounds at Mayo Clinic ⁦Mayo Clinic⁩ ⁦Tanios Bekaii-Saab, MD⁩

📣 Healthcare professionals — your invite is here! Get FREE registration to ISGIO 2025 with code CCF 🎟️ 🗓 Sept 12–13 📍 Austin, TX 🔗 gotoper.com/isgioccf Join Dr. Tanios Bekaii-Saab and Dr. Eileen O’Reilly at the International Symposium on Gastrointestinal Oncology (ISGIO)

📣🚨Alerting #Oncology colleagues & #fellows to a great academic #GIOncology career opportunity. The #Hem/#Onc Division Mayo Clinic Mayo Clinic Comprehensive Cancer Center in #Florida is seeking: ✅A #MedicalOncologist with interest/expertise in #Gastrointestinal #Cancers. 👇🏻 jobs.mayoclinic.org/job/jacksonvil…

ascopubs.org/doi/10.1200/JC… Final analysis of KN-585 is out: perioperative pembro+chemo in resectable gastric/GEJ cancer improved pCR. EFS and OS showed numerical improvement, but not statistically significant! .#Oncology #GICancer #Immunotherapy

Experience the 2025 International Symposium of Gastrointestinal Oncology (ISGIO) LIVE in Austin Tx or Streamed ONLINE ! 👉 FREE HCP Registration (USE CODE: ONCOALERT )🚨 buff.ly/KVngjav Join leading experts for two days of case-based learning, interactive panels, and

Experience the 2025 International Symposium of Gastrointestinal Oncology (ISGIO) LIVE in Austin Tx or Streamed ONLINE ! REGISTER HERE👉 buff.ly/KVngjav 👉 FREE HCP Registration (USE CODE: ONCOALERT )🚨 Join leading experts for two days of case-based learning,

A warm invite from PER 🚨to Join them In Person OR ONLINE (Streaming) at #ISGIO2025 Sept 12–13 in Austin, TX! REGISTER HERE👉 buff.ly/KVngjav FREE HCP Registration (USE CODE: ONCOALERT )🚨 A unique multidisciplinary GI oncology meeting with debates, case

OK, NET folks. Trying to make sense of systemic therapy sequencing for well diff GEP-NETs for a talk at the upcoming ISGIO conference. Good luck to me as the data are limited... 😂 How is that for introductory slides...?

Recent advances in HER2-directed therapy and chemoimmunotherapy are expanding the range of effective options for patients with #BiliaryTractCancer, reshaping the treatment landscape. Tanios Bekaii-Saab, MD Read here: onclive.com/view/her2-targ…

The treatment paradigms for gastrointestinal malignancies are being reshaped by new advancements, including chemoimmunotherapy for #EsophagealCancer and evolving first-line immunotherapy strategies for #HCC. Tanios Bekaii-Saab, MD Read more: onclive.com/view/how-chemo…

In an interview with Tanios Bekaii-Saab, MD, he outlined: 🌟Current treatment standards for advanced biliary tract cancers 🌟 The role of targeted therapies 🌟 The need for biomarker-driven immunotherapy selection and other ongoing research Read his insights: onclive.com/view/her2-targ…

In another interview, Tanios Bekaii-Saab, MD discussed: ✔️ The implications of the phase 3 NAPOLI-3 trial ✔️ The efficacy, tolerability, and real-world adoption of NALIRIFOX with FOLFIRINOX and gemcitabine/nab-paclitaxel ✔️ And more! Read his insights: onclive.com/view/ongoing-r…

Experience the 2025 International Symposium of Gastrointestinal Oncology (ISGIO) LIVE in Austin Tx or Streamed ONLINE ! REGISTER HERE👉 buff.ly/KVngjav 🚨 FREE HCP Registration (USE CODE: ONCOALERT ) Chairs Tanios Bekaii-Saab, MD Eileen M O’Reilly Faculty Thor Halfdanarson James J. Harding, MD

Significant advancements in #ColorectalCancer care highlight the power of optimized therapeutic sequencing. Gain expert insights with Tanios Bekaii-Saab, MD (@GIcancerdoc), in this #PeerView #MedEd activity, presented in partnership with Colorectal Cancer Alliance! bit.ly/4iAE6P6